Lebenthal Global Advisors’s Fulgent Genetics FLGT Stock Holding History

Lebenthal Global Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-847	Closed	-$44K	–	277
2020 Q4	$44K	Buy	+847	New	+$35.4K	0.03%	272

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lebenthal Global Advisors's FLGT Position: Q1 2021 in Review

Lebenthal Global Advisors sold out of Fulgent Genetics (FLGT) in Q1 2021, closing a stake of 847 shares — an estimated $44K sold.

Lebenthal Global Advisors first reported a position in FLGT in Q4 2020 and held it in 1 quarter. The position peaked at $44K in Q4 2020. 256 funds tracked by Wall St. Rank hold FLGT as of Q1 2021.

Lebenthal Global Advisors reported no remaining Fulgent Genetics position as of Q1 2021 after selling out during the quarter.
Lebenthal Global Advisors sold 847 Fulgent Genetics shares in Q1 2021, an estimated $44K.
Lebenthal Global Advisors first reported a position in Fulgent Genetics in Q4 2020 and held it in 1 quarter.
Lebenthal Global Advisors's Fulgent Genetics position peaked at $44K in Q4 2020.
256 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2021.

Based on Lebenthal Global Advisors's 13F filing for Q1 2021, filed 7 May 2021.